Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ferlitsch

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertensionR Schwarzer, D Kivaranovic, M Mandorfer, et al.
Endoscopy|August 8, 2001
Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluationA Ferlitsch, C Oesterreicher, J M Dumonceau, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severityM Mandorfer, P Schwabl, R Paternostro, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertensionM Mandorfer, B Scheiner, A F Stättermayer, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver diseaseP Schwabl, M Mandorfer, S Steiner, et al.
Gut|May 13, 2003
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shuntB Angermayr, M Cejna, F Karnel, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2018
Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleedingN Pfisterer, C Dexheimer, E-M Fuchs, et al.
Gastroenterology|October 31, 2000
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study GroupW Fischbach, B Dragosics, M E Kolve-Goebeler, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Alimentary Pharmacology & Therapeutics|November 7, 2017
Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertensionR Schwarzer, D Kivaranovic, M Mandorfer, et al.
Endoscopy|August 8, 2001
Diamond stents for palliation of malignant bile duct obstruction: a prospective multicenter evaluationA Ferlitsch, C Oesterreicher, J M Dumonceau, et al.
Alimentary Pharmacology & Therapeutics|January 30, 2018
Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severityM Mandorfer, P Schwabl, R Paternostro, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2018
Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertensionM Mandorfer, B Scheiner, A F Stättermayer, et al.
Alimentary Pharmacology & Therapeutics|July 17, 2015
Interferon-free regimens for chronic hepatitis C overcome the effects of portal hypertension on virological responsesM Mandorfer, K Kozbial, C Freissmuth, et al.
Alimentary Pharmacology & Therapeutics|December 3, 2016
Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver diseaseP Schwabl, M Mandorfer, S Steiner, et al.
Gut|May 13, 2003
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shuntB Angermayr, M Cejna, F Karnel, et al.
Alimentary Pharmacology & Therapeutics|February 2, 2018
Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleedingN Pfisterer, C Dexheimer, E-M Fuchs, et al.
Gastroenterology|October 31, 2000
Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study GroupW Fischbach, B Dragosics, M E Kolve-Goebeler, et al.
Pageof 5